Managed Healthcare Executive June 19, 2024
EndeavorOTC costs $24.99 monthly or $129.99 annually.
The FDA has approved EndeavorOTC to treat attention-deficit/hyperactivity disorder (ADHD) in adults, Akili announced yesterday in a press release. This is the first and only FDA-approved over-the-counter digital treatment for adult ADHD.
It is available for download in the United States on the Apple App Store and Google Play Store.
EndeavorRx, a version of EndeavorOTC designed for children with ADHD, was approved by the FDA in June 2020. Approval was granted after researchers noted that 68% of children in the trial experienced a clinically meaningful change after two months of playing. The full trial was published in The Lancet Digital Health journal. EndeavorRx is recommended to be used 25 minutes a day for...
Today's Sponsors
Today's Sponsor